, but is readily destroyed by heating at 56°C for half an hour. Cell cultures are also used to titrate the virus and to determine its purity by plaqueing. For example, the plaque type can be used to recognize parental properties in recombinants used as living influenza vaccines ( Figure 2) . The methods are also very much more reliable and efficient for the titration of viruses. Yellow fever virus, for example, can be more accurately and economically titrated in cell culture than in mice (Table 4) . Science 195, 834 Animal studies in drug safety evaluation Ralph Heywood PhD DrMedvet Huntingdon Research Centre, Huntingdon PE18 6ES
The term 'drug safety evaluation' is conventionally reserved for those predictive animal studies conducted on new medicines. Such experiments are normally prerequisite to the granting of clinical trial certificates for assessment in human volunteers prior to general release. Toxicological investigations are increasingly subject to criticism and scrutiny because, despite the large number of animal experiments performed, which in itself causes considerable public disquiet, we are apparently failing to predict accurately the human toxic hazard of many compounds; for example practolol, diethylstilboestrol, vinyl chloride and clioquinol. Although the concept of absolute safety cannot be realized, it is important to appreciate the limitations of animal studies as predictive models. The present situation is further complicated by the almost universal acceptance of guidelines and draft protocols, which has effectively stifled initiative in experimentation and no longer encourages open-ended argument.
All toxicological studies are directed towards demonstrating a dose-response relationship. This concept is the only fundamental law of toxicology. The scope of suggested or obligatory testing procedures in animals varies according to the category of the substance and with the duration and intensity of exposure. At one end of the scale there is simply an LD50 determination; at the other end is the long-term animal toxicity trial.
Journal of the Royal Society of Medicine Volume 71 September 1978 687 There has to be some starting point; this has generally been accepted as the LD50 -that dose at which 50%O of a population of the same species will die within a specified time. The value of this determination is being questioned, particularly with respect to the manifestation of toxicity. Acutely poisoned animals usually present with inappetance and lethargy, sit in a huddled posture and show abnormal body carriage; piloerection and ptosis often occur, but all these are nonspecific signs. Death usually occurs within 24 hours, but the manner of dying contributes little to defining target organs or systems. Animals involved in an LD50 test are usually maintained for 14 days. In theory this is to detect delayed toxicity; in practice we are watching prolonged toxicity.
The US Federal Hazardous Substances Act defines as highly toxic any substance that produces 50% mortality in 200 g rats following a single oral dose of less than 50 mg/kg; or in similar rats inhaling for 1 hour an atmospheric concentration of less than 200 parts per million by volume of gas or vapour; or in rabbits tested at a dosage level of less than 200 ml/kg body weight with a compound administered by continuous contact with the bare skin for less than 24 hours. If 1 g/kg can be given per os, the compound can be regarded as relatively nontoxic; but if 16 g/kg can be given, it is reasonable to suggest that, for all practical purposes, the material is nontoxic. It is tempting to reduce a series of imponderables to a number and to substitute arithmetic for judgment, but it is important not to attach too great an authority to this LD50 value.
The conventional chronic long-term toxicity study remains a key feature in safety assessment. It is required that these studies be carried out in two speciesa rodent and a nonrodent. Animal studies are essentially comparative in that the spontaneous and induced pathological manifestations are compared in control and test animals simultaneously. It is essential to determine whether an observation or finding is attributable to the test compound and, if so, whether its incidence is dose-related. Clinicopathological findings can be categorized into three groups: the recognized common pathology of the species under investigation; changes predictable by virtue of the pharmacology of the compound; and manifestations of unusual and unpredicted responses.
Ideally, metabolic data should be available before setting up long-term toxicity studies. However, this is rarely available and all that are usually known are the peak plasma concentrations and excretion rates in urine and faeces.
The long-term study has been adversely criticized on the grounds of inadequate animal numbers and of unrealistic dose rates. Barnes & Denz (1954) calculated that some 295 animals would have to be tested in order to give a 95% probability of observing at least once a toxic effect that occurs in only 1% of animals. With non-rodents, group sizes of this order are not feasible and with rodents they would not be economical.
The conventional procedure for the long-term study is to have one control group and at least three groups of dosed animals. The lowest dose rate is usually comparable on a body weight basis with the intended human therapeutic dose or a small multiple thereof. The highest dose is intended to establish the target organs or systems for toxic effects, providing a so-called effect level and perhaps thereby giving clues as to the countermeasures or antidotal treatment. The intermediate dose is a multiple of the proposed therapeutic dose and is intended to establish safety factors. During the studies, the animals are subjected to regular clinical examinations and body weight measurements, with food intake and water intake calculated. Blood and urine are subjected to a gamut of biochemical and cytological examinations, Most of these tests are based on human clinical pathology and are often irrelevant. At termination, post-mortem examination is accompanied by organ weight analysis and histopathological examination. One of the complicating factors in interpreting histopathology relates to the time of onset and maturation of the lesion. In many toxicity studies there is a remarkable lack of consistency with respect to target organs identified between species. Should the same target organ be identified in rodents and non-rodents, there are often considerable differences as to dose levels and times taken to induce the effects.
The reproductive studies are aimed at assessment of possible effects on gametogenesis, embryo-fetal and postnatal development; there are three basic studies and as with chronic toxicity studies, there should be three test groups compared to a control group. In the fertility and general reproductive study, males are treated for at least 60 days and females for 14 days prior to mating, the treatment continuing through mating, gestation and finally lactation. The length of administration may give rise to considerable practical problems, such as those involved in continual long-term intravenous injection of small rodents. Of more importance is the fact that a rat can develop detoxification mechanisms with remarkable rapidity, by enzyme induction, and male rats dosed for this 60-day period might be so affected. Another objection might be made to the fact that some drug-induced activities might show up only in the first few days of administration.
The second section comprises the classical teratology study with pregnant animals dosed during the period of organogenesis: days 6-18 for rabbits and 6-15 for rats. Rats, mice and rabbits are susceptible to a number of teratogens; the question is, have reactions in these species any special relevance to similar reactions in man?
It is probable that there is no real difference at the embryonic level between any of the species. The early somite stage is very similar in all mammals; it is only organogenesis that is different. However, it is important that the dosage level approaches the embryonic LD50. The arguments at the moment as to the choice of animal species are irrelevant as there is no best animal. In these teratological studies emphasis has been placed on malformations, and many comparative studies have been found to give conflicting results. Palmer (1977) states that emphasis should be taken away from the malformations and we should look for adverse effects such as maternal toxicity and embryonic death, abortion, and fetal growth retardation. There is a fundamental lack of knowledge of pathogenesis of most malformations and, therefore, extrapolation to man has to be done with reservation and care. Negative results cannot be used to predict that an agent will lack teratogenic effect in man. Another point that must be borne in mind is that when malformations occur, these are multifactorial and the threshold of predisposition can be shifted by a number of environmental factors. The nongenetic factors, such as season, timing, health, parental age, method of dosing, can have considerable influence. Surprisingly few compounds have been shown to be teratogenic in man although a large number, including aspirin, steroids, vitamins A and B, insulin and hydantoins, have been shown to be teratogens in rats. Detection of nonstructural malformations is even more difficult, for very subtle anatomical and biochemical changes can induce functional abnormalities. Lewis et al. (1977) have shown reserpine to interfere with cell proliferation in the brains of suckling rats, and long-term alterations in behaviour may be attributable to the effect of the drug. It is argued tha-t other compounds influencing central neurotransmitter activity may affect the developing brain. There is a problem in defining the relevance of the rodent model, particularly in this area of brain development, where there is wide interspecies variation in the velocity and timing of brain development (Dobbing 1970) . Completing the third segment of these reproductive studies is the peri-and postnatal study, in which groups of females are treated during the last third of pregnancy and throughout lactation until weaning. Short-term carcinogenicity tests have been reviewed by Purchase et al. (1976) ; the only test which gave reliable results was the Ames test, detecting mutagenic action on Salmonella typhimurium cultured with rat liver microsomes, i.e. following metabolic activation. The test predicted the activity of 106 out of 120 compounds. Vinyl chloride and diethylstilboestrol did not react positively. The other 12 compounds, over which the tests disagreed, represented 6 established carcinogens and 6 supposedly noncarcinogens. There would appear to be no reliable alternative to long-term bioassay in experimental animals where experience has indicated that compounds which are carcinogenic in humans are also carcinogenic in one or more experimental animal bioassay systems.
Toxicology is a science without a scientific underpinning, which draws on basic sciences such as pharmacology, biochemistry, pathology and veterinary medicine. The toxicologist has turned his attention to the mechanics of how to carry out studies, and the Good Laboratory Practice code from the Food and Drug Administration should help to provide more reliable animal data, but will certainly not help to interpret this data. There is a lack of fundamental knowledge on the mechanisms of toxic compounds. If the mechanisms were known, choice of species, drug administration procedures and interpretation of results would be relatively easy and the animal data might then be appropriately extrapolated to man.
